Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus

Colesevelam possesses antidiabetic properties, which could potentiate sulphonylurea or insulin‐induced hypoglycemia; clinically significant hypoglycemia, as a side effect to bile acid sequestrants, may be under‐recognized in clinical practice.

Detalles Bibliográficos
Autores principales: Pavlou, Panagiotis, Koutroukas, Vaios, Lissett, Catherine, Smith, Jamie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517595/
https://www.ncbi.nlm.nih.gov/pubmed/34691455
http://dx.doi.org/10.1002/ccr3.4830
_version_ 1784584052964065280
author Pavlou, Panagiotis
Koutroukas, Vaios
Lissett, Catherine
Smith, Jamie C.
author_facet Pavlou, Panagiotis
Koutroukas, Vaios
Lissett, Catherine
Smith, Jamie C.
author_sort Pavlou, Panagiotis
collection PubMed
description Colesevelam possesses antidiabetic properties, which could potentiate sulphonylurea or insulin‐induced hypoglycemia; clinically significant hypoglycemia, as a side effect to bile acid sequestrants, may be under‐recognized in clinical practice.
format Online
Article
Text
id pubmed-8517595
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85175952021-10-21 Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus Pavlou, Panagiotis Koutroukas, Vaios Lissett, Catherine Smith, Jamie C. Clin Case Rep Case Report Colesevelam possesses antidiabetic properties, which could potentiate sulphonylurea or insulin‐induced hypoglycemia; clinically significant hypoglycemia, as a side effect to bile acid sequestrants, may be under‐recognized in clinical practice. John Wiley and Sons Inc. 2021-10-15 /pmc/articles/PMC8517595/ /pubmed/34691455 http://dx.doi.org/10.1002/ccr3.4830 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Pavlou, Panagiotis
Koutroukas, Vaios
Lissett, Catherine
Smith, Jamie C.
Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
title Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
title_full Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
title_fullStr Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
title_full_unstemmed Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
title_short Colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
title_sort colesevelam‐induced hypoglycaemia in a patient with type 1 diabetes mellitus
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517595/
https://www.ncbi.nlm.nih.gov/pubmed/34691455
http://dx.doi.org/10.1002/ccr3.4830
work_keys_str_mv AT pavloupanagiotis colesevelaminducedhypoglycaemiainapatientwithtype1diabetesmellitus
AT koutroukasvaios colesevelaminducedhypoglycaemiainapatientwithtype1diabetesmellitus
AT lissettcatherine colesevelaminducedhypoglycaemiainapatientwithtype1diabetesmellitus
AT smithjamiec colesevelaminducedhypoglycaemiainapatientwithtype1diabetesmellitus

Ejemplares similares